Close Menu

Hammer on THOR

A long non-coding RNA dubbed THOR might have a key role in cancer development and could be a potential drug target, according to a new study from University of Michigan researchers.

Michigan's Arul Chinnaiyan and his colleagues sifted through a compendium of lncRNAs they recently developed using large-scale RNA sequencing. Through this, they uncovered 82 highly conserved lncRNAs, including THOR, as they report in Cell this week.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.